癌症
癌癥
암증
CHINESE JOURNAL OF CANCER
2001年
2期
168-170
,共3页
王得坤%郑俊猛%姜海明%张柱林%张镜芳%欧阳能太
王得坤%鄭俊猛%薑海明%張柱林%張鏡芳%歐暘能太
왕득곤%정준맹%강해명%장주림%장경방%구양능태
肺肿瘤%bcl-2%细胞凋亡%免疫逃避
肺腫瘤%bcl-2%細胞凋亡%免疫逃避
폐종류%bcl-2%세포조망%면역도피
目的:观察体外培养肺癌细胞bcl-2表达与机体免疫攻击致癌细胞凋亡的关系。方法:把bcl-2表达不同的肺癌细胞株与从肺癌组织中分离出来的肿瘤浸润淋巴细胞(tumorinfiltratinglymphocyte,TIL)共同培养,通过JAM试验观察肺癌细胞凋亡的情况。结果:体外JAM试验中,随着TIL浓度增加,bcl-2阴性的肺癌细胞凋亡也增加,但bcl-2阳性者则无变化。结论:bcl-2表达阳性的肺癌细胞具有抗凋亡特性,能耐受肿瘤浸润淋巴细胞的免疫攻击。
目的:觀察體外培養肺癌細胞bcl-2錶達與機體免疫攻擊緻癌細胞凋亡的關繫。方法:把bcl-2錶達不同的肺癌細胞株與從肺癌組織中分離齣來的腫瘤浸潤淋巴細胞(tumorinfiltratinglymphocyte,TIL)共同培養,通過JAM試驗觀察肺癌細胞凋亡的情況。結果:體外JAM試驗中,隨著TIL濃度增加,bcl-2陰性的肺癌細胞凋亡也增加,但bcl-2暘性者則無變化。結論:bcl-2錶達暘性的肺癌細胞具有抗凋亡特性,能耐受腫瘤浸潤淋巴細胞的免疫攻擊。
목적:관찰체외배양폐암세포bcl-2표체여궤체면역공격치암세포조망적관계。방법:파bcl-2표체불동적폐암세포주여종폐암조직중분리출래적종류침윤림파세포(tumorinfiltratinglymphocyte,TIL)공동배양,통과JAM시험관찰폐암세포조망적정황。결과:체외JAM시험중,수착TIL농도증가,bcl-2음성적폐암세포조망야증가,단bcl-2양성자칙무변화。결론:bcl-2표체양성적폐암세포구유항조망특성,능내수종류침윤림파세포적면역공격。
Objective: The current study was designed to investigate the relationship between bcl-2 expression and apoptosis of lung cancer cells in vitro. Methods:Lung cancer cell lines with different expression of bcl-2 were cocultured with tumor infiltrating lymphocyte(TIL) isolated from fresh tumor samples,and JAM test was performed to evaluate apoptosis of cancer cells. Immunohistochemistry and TUNEL assay were used to determine bcl-2 expression and apoptosis of tissue sections of lung cancers respectively. Results: As shown in JAM test, apoptosis increased with the elevation of TIL in coculturing assay in bcl-2 negative cancer cell lines, but in one of bcl-2 positive cell lines it remained stable. Conclusions: Lung cancer cells with bcl-2 expression may antagonize apoptosis, which may account for their immune evasion mechanism.